Ottawa, Canada, Feb. 06, 2020 (GLOBE NEWSWIRE) — Orion Biotechnology Canada Ltd., a clinical-stage company, today announced the addition of Dr. Andreas Harstrick to its Scientific
Orion Biotechnology Reports Additional Positive Preclinical Data for OB-002 in the Treatment of Colorectal Cancer
OTTAWA, Ontario, June 20, 2019 (Newswire.com) – Orion Biotechnology Canada Ltd., today announced new preclinical data evaluating the efficacy of OB-002 (5P12-RANTES) in colorectal cancer.
The National Centre for Research and Development Awards Orion Biotechnology With a Grant to Progress Development of a Treatment for Advanced Colorectal Cancer
OTTAWA, Ontario, April 16, 2019 (Newswire.com) – Orion Biotechnology Canada Ltd., a developer of novel medical treatments, today announced that its European subsidiary Orion Biotechnology